Trending

#multiple_sclerosis

Latest posts tagged with #multiple_sclerosis on Bluesky

Latest Top
Trending

Posts tagged #multiple_sclerosis

Preview
Empowering Multiple Sclerosis Patients Through Self-Advocacy Awareness in March March is MS Awareness Month and the MSAA launches a campaign focusing on self-advocacy strategies, fostering cooperation between patients and healthcare providers.

Empowering Multiple Sclerosis Patients Through Self-Advocacy Awareness in March #None #Multiple_Sclerosis #Cherry_Hill #MSAA #Self-Advocacy

0 0 0 0
Preview
Immunic Showcases Promising Phase 2 CALLIPER Data for Vidofludimus Calcium at 2026 ACTRIMS Forum Immunic, Inc. to present new findings from the Phase 2 CALLIPER trial of Vidofludimus Calcium at the upcoming ACTRIMS Forum 2026, emphasizing its potential in treating progressive multiple sclerosis.

Immunic Showcases Promising Phase 2 CALLIPER Data for Vidofludimus Calcium at 2026 ACTRIMS Forum #United_States #San_Diego #Multiple_Sclerosis #Immunic #Vidofludimus_Calcium

1 0 0 0
Preview
Exploring the Connection Between Wearable Data and MRI Metrics in MS Patients A recent study unveils the potential of wearable device data to monitor disease progression in multiple sclerosis patients, featured in the Journal of Neuroimmunology.

Exploring the Connection Between Wearable Data and MRI Metrics in MS Patients #Japan #Multiple_Sclerosis #Sapporo #Tech_Doctor #neuroimmunology

0 0 0 0
Preview
Revolutionary Study Affirms NB-UVB Phototherapy's Role in Treating Multiple Sclerosis A recent study confirms that NB-UVB phototherapy significantly reduces inflammation in multiple sclerosis patients, highlighting its therapeutic potential beyond dermatological use.

Revolutionary Study Affirms NB-UVB Phototherapy's Role in Treating Multiple Sclerosis #USA #Multiple_Sclerosis #Cytokind #NB-UVB #Intervale

0 0 0 0
Preview
Shaping Tomorrow Together: Empowering the Voices of Multiple Sclerosis Patients The initiative, Shaping Tomorrow Together, aims to elevate the insights of people living with multiple sclerosis to inform future treatments and therapies.

Shaping Tomorrow Together: Empowering the Voices of Multiple Sclerosis Patients #USA #Washington #Multiple_Sclerosis #National_MS_Society #Shaping_Tomorrow

0 0 0 0
Preview
Noninvasive Brain Stimulation Device Shows Promise in Reducing Cannabis Addiction for MS Patients A new study reveals that a noninvasive device may help individuals with multiple sclerosis reduce cannabis dependency, offering hope for effective treatment.

Noninvasive Brain Stimulation Device Shows Promise in Reducing Cannabis Addiction for MS Patients #United_States #New_York #Multiple_Sclerosis #Brain_Stimulation #Cannabis_Addiction

0 0 0 0
Post image Post image Post image Post image

Back from #ECTRIMS2025 in Barcelona! Where Claudia Rodriguez-Lopez masterfully presented our work “Progressive demyelination, neuroinflammation and disability by brain TAF1 alteration found in #multiple_sclerosis”, selected for Best of ECTRIMS Slide Deck!
@cbm-csic-uam.bsky.social
@uam.es @csic.es

5 1 1 0
Preview
New Study Highlights Kesimpta® Efficacy in Relapsing MS Patients Switching from Oral Therapies Recent findings reveal that Kesimpta® shows remarkable effectiveness in treating relapsing multiple sclerosis, especially after switching from oral therapies.

New Study Highlights Kesimpta® Efficacy in Relapsing MS Patients Switching from Oral Therapies #United_States #Multiple_Sclerosis #Novartis #East_Hanover #Kesimpta

0 0 0 0
Preview
Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona Neuraxpharm highlights its dedication to multiple sclerosis treatment at ECTRIMS 2025 in Barcelona, showcasing innovative therapies in CNS disorders.

Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona #Spain #Barcelona #Multiple_Sclerosis #Neuraxpharm #ECTRIMS

1 0 0 0
Preview
National Multiple Sclerosis Society Revolutionizes MS Diagnosis with Updated McDonald Criteria The National Multiple Sclerosis Society has updated the McDonald Diagnostic Criteria, streamlining the MS diagnosis process to enable quicker and more accurate results for patients.

National Multiple Sclerosis Society Revolutionizes MS Diagnosis with Updated McDonald Criteria #United_States #New_York #Multiple_Sclerosis #MS_Society #McDonald_Criteria

0 0 0 0
Preview
Immunic's Patent Approval Marks Milestone for Vidofludimus Calcium in Multiple Sclerosis Treatment Immunic, Inc. has secured a U.S. patent for Vidofludimus Calcium, critical for treating progressive multiple sclerosis, offering significant market protection.

Immunic's Patent Approval Marks Milestone for Vidofludimus Calcium in Multiple Sclerosis Treatment #United_States #New_York #Multiple_Sclerosis #Immunic #Vidofludimus

0 0 0 0
Preview
Immunic, Inc. Reveals Promising Second Quarter Results and Drug Advancements Immunic, Inc. has reported significant clinical advancements and financial results for the second quarter of 2025, including updates on its lead drug, vidofludimus calcium.

Immunic, Inc. Reveals Promising Second Quarter Results and Drug Advancements #USA #New_York #Multiple_Sclerosis #Immunic #Vidofludimus_Calcium

0 0 0 0
Preview
Explore Free Educational Resources from the Multiple Sclerosis Association of America The Multiple Sclerosis Association of America offers free educational videos and webinars for those affected by MS. Discover valuable insights now.

Explore Free Educational Resources from the Multiple Sclerosis Association of America #United_States #Multiple_Sclerosis #Cherry_Hill #MSAA #MSi_Video_Library

0 0 0 0
Preview
Immunic Presents Promising Long-Term Data on Vidofludimus Calcium for MS Patients at Phase 2 EMPhASIS Trial Immunic, Inc. has revealed new long-term data from the Phase 2 EMPhASIS trial for Vidofludimus Calcium, showcasing its efficacy in managing relapsing-remitting MS.

Immunic Presents Promising Long-Term Data on Vidofludimus Calcium for MS Patients at Phase 2 EMPhASIS Trial #USA #New_York #Multiple_Sclerosis #Immunic #Vidofludimus

0 0 0 0
Post image Post image

So proud of Claudia Rodríguez-López for her brilliant defense of her Doctoral Thesis entitled “TAF1-dependent transcriptional dysregulation underlies multiple sclerosis”
@cbm-csic-uam.bsky.social @csic.es
@felixhernandezp.bsky.social
#esclerosis_múltiple
#multiple_sclerosis
#ciberned

2 0 1 0
Preview
Breakthrough Efficacy of Equecabtagene Autoleucel Presented at EAN Congress for MS Treatment At the 11th EAN Congress, IASO Bio showcased promising results from a study on Equecabtagene Autoleucel, an innovative MS therapy, indicating significant improvements in patient conditions.

Breakthrough Efficacy of Equecabtagene Autoleucel Presented at EAN Congress for MS Treatment #China #Shanghai #Multiple_Sclerosis #IASO_Bio #Equecabtagene

0 0 0 0
Preview
Dog's Near-Fatal Encounter with Multiple Sclerosis Medication Highlights Pet Safety Concerns A heartwarming yet alarming story reveals the near-fatal incident involving Kaya the dog, who mistakenly ingested a dangerous MS medication and overcame the odds with swift veterinary care.

Dog's Near-Fatal Encounter with Multiple Sclerosis Medication Highlights Pet Safety Concerns #United_States #Multiple_Sclerosis #Pet_Poison_Helpline #Cedar_Rapids #Kaya_the_Dog

0 0 0 0
Preview
Rapid Growth of the Multiple Sclerosis Market Forecasted with a 3.8% CAGR from 2025 to 2034 The Multiple Sclerosis market is projected to expand significantly, driven by advancements in treatment and increased prevalence, with a CAGR of 3.8% until 2034.

Rapid Growth of the Multiple Sclerosis Market Forecasted with a 3.8% CAGR from 2025 to 2034 #None #Multiple_Sclerosis #DMTs #BTK_Inhibitors

0 0 0 0
Preview
Immunic Completes Enrollment for Phase 3 Trials of Vidofludimus Calcium in Multiple Sclerosis Immunic, a biotechnology firm, has concluded participant enrollment for its Phase 3 ENSURE trials exploring vidofludimus calcium in relapsing multiple sclerosis, signaling progress in treatment options.

Immunic Completes Enrollment for Phase 3 Trials of Vidofludimus Calcium in Multiple Sclerosis #United_States #New_York #Multiple_Sclerosis #Immunic #Vidofludimus_Calcium

0 0 0 0
Preview
Join the 11th Improving Lives Benefit: A Celebration for the MS Community The 11th Improving Lives Benefit hosted by MSAA aims to support the MS community through inspiring programs, auctions, and networking opportunities in Philadelphia.

Join the 11th Improving Lives Benefit: A Celebration for the MS Community #USA #Philadelphia #Multiple_Sclerosis #Tyler_Campbell #Cionic

0 0 0 0
Preview
Biostate AI and Accelerated Cure Project Join Forces to Innovate MS Treatment with AI Models Biostate AI has partnered with the Accelerated Cure Project to develop advanced AI models aimed at enhancing multiple sclerosis treatment, leveraging extensive RNA data.

Biostate AI and Accelerated Cure Project Join Forces to Innovate MS Treatment with AI Models #United_States #Houston #Multiple_Sclerosis #Accelerated_Cure_Project #Biostate_AI

0 0 0 0

It’s my greatest pleasure to join the Bluesky community to broaden my network, to follow the pioneers and to communicate with peers.
#Multiple_sclerosis #neurology #MS #research #MRI #fMRI

1 0 0 0
Preview
Accelerated Cure Project Unveils AI Resource for MS Caregivers Available Around the Clock Accelerated Cure Project has launched a transformative AI tool for caregivers of MS patients, providing reliable answers 24/7 to support their needs.

Accelerated Cure Project Unveils AI Resource for MS Caregivers Available Around the Clock #United_States #Multiple_Sclerosis #Waltham #Accelerated_Cure_Project #AI_Caregiving_Expert

0 0 0 0
Preview
Community Comes Together for Fun and Philanthropy at Kalfus & Nachman's MS Fundraiser Join Kalfus & Nachman on March 28, 2025, as they host a unique fundraising event in Norfolk, VA, supporting Multiple Sclerosis research and advocacy.

Community Comes Together for Fun and Philanthropy at Kalfus & Nachman's MS Fundraiser #United_States #Multiple_Sclerosis #Norfolk #Fundraiser #Kalfus_Nachman

0 0 0 0
Preview
National MS Society Introduces New Campaign to Promote Awareness and Support During MS Awareness Week The National Multiple Sclerosis Society launches the impactful 'Tell MS It Ends With Us' campaign during MS Awareness Week to engage and educate.

National MS Society Introduces New Campaign to Promote Awareness and Support During MS Awareness Week #United_States #New_York #Multiple_Sclerosis #MS_Awareness #National_MS_Society

0 0 0 0
Preview
New Treatment Approach Aims to Close Gap for MS Patients of Color A pioneering algorithm may significantly reduce treatment disparities faced by Hispanic and Black individuals with multiple sclerosis by guiding effective treatment options.

New Treatment Approach Aims to Close Gap for MS Patients of Color #USA #San_Diego #Multiple_Sclerosis #Health_Disparities #treatment_algorithm

0 0 0 0
Preview
Empowering the MS Community: March Recognized as MS Awareness Month by MSAA During March, the Multiple Sclerosis Association of America presents initiatives to empower those diagnosed with MS, focusing on self-advocacy and support.

Empowering the MS Community: March Recognized as MS Awareness Month by MSAA #United_States #Multiple_Sclerosis #Cherry_Hill #MSAA #MS_Awareness

0 0 0 0
Preview
Immunic Showcases Vidofludimus Calcium Research at ACTRIMS 2025 Forum Immunic, Inc. unveiled detailed findings on Vidofludimus Calcium at the ACTRIMS Forum 2025, offering hope for multiple sclerosis treatments.

Immunic Showcases Vidofludimus Calcium Research at ACTRIMS 2025 Forum #United_States #Multiple_Sclerosis #West_Palm_Beach #Immunic #Vidofludimus_Calcium

0 0 0 0
Preview
National Multiple Sclerosis Society Strengthens Leadership with New Appointments The National Multiple Sclerosis Society has appointed Stephanie Davidson and Lauren Hall to enhance its mission-driven leadership team, focusing on MS advocacy and support.

National Multiple Sclerosis Society Strengthens Leadership with New Appointments #USA #New_York #Multiple_Sclerosis #NMSS #Health_Leaders

0 0 0 0
Preview
Growth of Multiple Sclerosis Market in the US Driven by AI Innovations and Strong Vendor Pipeline The US multiple sclerosis market is set to expand by USD 4.99 billion from 2025 to 2029, spurred by AI advancements and robust vendor collaboration.

Growth of Multiple Sclerosis Market in the US Driven by AI Innovations and Strong Vendor Pipeline #United_States #New_York #AI_Innovations #Multiple_Sclerosis #Healthcare_Market

0 0 0 0